Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae?

DiMeglio LA, Tosh A, Saha C, Estes M, Mund J, Mead LE, Lien I, Ingram DA, Haneline LS.

J Pediatr. 2010 Oct;157(4):540-6. doi: 10.1016/j.jpeds.2010.04.050. Epub 2010 Jun 12.

2.

Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria.

Sibal L, Aldibbiat A, Agarwal SC, Mitchell G, Oates C, Razvi S, Weaver JU, Shaw JA, Home PD.

Diabetologia. 2009 Aug;52(8):1464-73. doi: 10.1007/s00125-009-1401-0. Epub 2009 May 30.

PMID:
19484217
3.

Comparative analysis of methods for assessment of circulating endothelial progenitor cells.

George J, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A.

Tissue Eng. 2006 Feb;12(2):331-5.

PMID:
16548691
4.

Gestational diabetes mellitus alters maternal and neonatal circulating endothelial progenitor cell subsets.

Acosta JC, Haas DM, Saha CK, Dimeglio LA, Ingram DA, Haneline LS.

Am J Obstet Gynecol. 2011 Mar;204(3):254.e8-254.e15. doi: 10.1016/j.ajog.2010.10.913. Epub 2010 Dec 16.

5.

Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.

Massa M, Rosti V, Ramajoli I, Campanelli R, Pecci A, Viarengo G, Meli V, Marchetti M, Hoffman R, Barosi G.

J Clin Oncol. 2005 Aug 20;23(24):5688-95.

6.

Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction.

Maiorino MI, Bellastella G, Petrizzo M, Della Volpe E, Orlando R, Giugliano D, Esposito K.

Endocrine. 2015 Jun;49(2):415-21. doi: 10.1007/s12020-014-0478-5. Epub 2014 Nov 20.

PMID:
25411101
7.

Relationship between circulating endothelial progenitor cells and endothelial dysfunction in children with type 1 diabetes: a novel paradigm of early atherosclerosis in high-risk young patients.

Głowińska-Olszewska B, Moniuszko M, Hryniewicz A, Jeznach M, Rusak M, Dąbrowska M, Łuczyński W, Bodzenta-Łukaszyk A, Bossowski A.

Eur J Endocrinol. 2013 Jan 17;168(2):153-61. doi: 10.1530/EJE-12-0857. Print 2013 Feb.

8.

Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells.

Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL.

Br J Haematol. 2001 Oct;115(1):186-94.

PMID:
11722432
9.

Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations.

Shaffer RG, Greene S, Arshi A, Supple G, Bantly A, Moore JS, Mohler ER 3rd.

Cytometry B Clin Cytom. 2006 Mar;70(2):56-62.

10.

Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction.

Boilson BA, Kiernan TJ, Harbuzariu A, Nelson RE, Lerman A, Simari RD.

Nat Clin Pract Cardiovasc Med. 2008 Aug;5(8):489-96. doi: 10.1038/ncpcardio1277. Epub 2008 Jun 24.

11.

Endothelial cells (EC) and endothelial precursor cells (EPC) kinetics in hematological patients undergoing chemotherapy or autologous stem cell transplantation (ASCT).

Kideryová L, Pytlík R, Benešová K, Veselá R, Karban J, Rychtrmocová H, Goettsch W, Morawietz H, Trněný M.

Hematol Oncol. 2010 Dec;28(4):192-201. doi: 10.1002/hon.941.

PMID:
21136582
12.

Glucose-induced increase in circulating progenitor cells is blunted in polycystic amenorrhoeic subjects.

Bairagi S, Gopal J, Nathan AA, Babu SS, Kumar NP, Dixit M.

Hum Reprod. 2012 Mar;27(3):844-53. doi: 10.1093/humrep/der457. Epub 2012 Jan 16.

13.

Effect of moderate-to-severe chronic kidney disease on flow-mediated dilation and progenitor cells.

Kuczmarski JM, Darocki MD, DuPont JJ, Sikes RA, Cooper CR, Farquhar WB, Edwards DG.

Exp Biol Med (Maywood). 2011 Sep;236(9):1085-92. doi: 10.1258/ebm.2011.011008. Epub 2011 Jul 26.

PMID:
21791552
14.

Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus.

Yue WS, Lau KK, Siu CW, Wang M, Yan GH, Yiu KH, Tse HF.

Cardiovasc Diabetol. 2011 Dec 20;10:113. doi: 10.1186/1475-2840-10-113.

15.

Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.

Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML, Gillebert TC, Plum J, Vandekerckhove B.

Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1572-9. Epub 2007 May 10.

16.

The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study.

West DJ, Campbell MD, Gonzalez JT, Walker M, Stevenson EJ, Ahmed FW, Wijaya S, Shaw JA, Weaver JU.

Cardiovasc Diabetol. 2015 Jun 5;14:71. doi: 10.1186/s12933-015-0235-y.

17.

Endothelial progenitor cells and left ventricle function in patients with acute myocardial infarction: potential therapeutic considertions.

Kuliczkowski W, Derzhko R, Prajs I, Podolak-Dawidziak M, Serebruany VL.

Am J Ther. 2012 Jan;19(1):44-50. doi: 10.1097/MJT.0b013e3181e0cab3.

PMID:
20535003
18.

Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease.

Padfield GJ, Tura-Ceide O, Freyer E, Barclay GR, Turner M, Newby DE, Mills NL.

Heart. 2013 Jun;99(11):791-8. doi: 10.1136/heartjnl-2012-302949. Epub 2013 Feb 6.

PMID:
23390050
19.

Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapy.

da Silva EF, Fonseca FA, França CN, Ferreira PR, Izar MC, Salomão R, Camargo LM, Tenore SB, Lewi DS.

AIDS. 2011 Aug 24;25(13):1595-601. doi: 10.1097/QAD.0b013e32834980f4.

PMID:
21673561
20.

Endothelial progenitor cells with Alzheimer's disease.

Kong XD, Zhang Y, Liu L, Sun N, Zhang MY, Zhang JN.

Chin Med J (Engl). 2011 Mar;124(6):901-6.

Items per page

Supplemental Content

Write to the Help Desk